Skip Navigation LinksHome > July/August 2011 - Volume 35 - Issue 4 > Gd-EOB-DTPA as a Functional MR Cholangiography Contrast Agen...
Journal of Computer Assisted Tomography:
doi: 10.1097/RCT.0b013e31821f4e29
Abdominal Imaging

Gd-EOB-DTPA as a Functional MR Cholangiography Contrast Agent: Imaging Gallbladder Filling in Patients With and Without Hepatobiliary Dysfunction

Smith, Andrew Dennis MD, PhD; Veniero, Joseph C. MD, PhD

Collapse Box


Objective: To evaluate cystic duct patency on hepatobiliary-phase magnetic resonance (MR) images after intravenous gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid (Gd-EOB-DTPA) administration.

Methods: A radiology information system search identified patients with gallbladders that had MR imaging after intravenous Gd-EOB-DTPA injection. No patients had acute cholecystitis. Magnetic resonance image findings were correlated with clinical notes, other imaging studies, time of contrast injection, and serum laboratory tests.

Results: Contrast accumulated in the gallbladder in 80% of patients (n = 100) with hepatobiliary-phase MR imaging at a median of 22 minutes (range, 15-83 minutes). Absence of contrast accumulation in the gallbladder (n = 20) was associated with hepatobiliary imaging less than 30 minutes after contrast administration, gallbladder contraction, cholelithiasis, elevated liver function tests, elevated bilirubin, and cirrhosis.

Conclusions: Functional assessment of cystic duct patency by Gd-EOB-DTPA-enhanced liver MR is best conducted when hepatobiliary-phase T1-weighted imaging is delayed by more than 30 minutes after contrast injection. Hepatobiliary dysfunction is associated with nonfilling of the gallbladder.

Copyright © 2011 Wolters Kluwer Health, Inc. All rights reserved.



Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.